Entering text into the input field will update the search result below

DexCom - Insulet buyout deal unlikely, Bank of America says

May 24, 2022 8:13 AM ETDexCom, Inc. (DXCM) Stock, PODD StockMDT, TNDMBy: Dulan Lokuwithana, SA News Editor

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

Commenting on the reports that the medical device company DexCom (NASDAQ:DXCM) is in talks to acquire the insulin pump maker Insulet (NASDAQ:PODD), a group of analysts at Bank of America argues that

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
PODD
--
DXCM
--